HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens.

AbstractOBJECTIVE:
To study serum type I interferon (IFN) activity in patients with early systemic sclerosis (SSc).
METHOD:
Serum type I IFN activity was measured in 33 consecutive patients with SSc and a disease duration of < 2 years and in 13 healthy individuals by calculating a type I IFN score according to the induction of six IFN-α regulated genes in a reporter cell line.
RESULTS:
Twenty-seven per cent of the SSc patients had an increased type I IFN score compared to none of the healthy individuals (p < 0.05). The clinical SSc phenotype associated with high serum type I IFN activity did not differ from patients with low serum type I IFN activity regarding the presence of skin or lung fibrosis, pulmonary hypertension, or digital complications. Patients with high serum type I IFN activity were younger (p < 0.01) and had a lower frequency of cardiac involvement (p = 0.053), lower leucocyte count (p < 0.001), higher immunoglobulin (Ig)G levels (p < 0.05), and a higher amount of antibodies against extractable nuclear antigens (p < 0.01) than patients with low serum type I IFN activity. The presence of antibodies against topoisomerase I, Sjögren's syndrome antigen, and nuclear ribonucleoprotein antigens was associated with higher type I IFN activity (p < 0.05 for all comparisons).
CONCLUSIONS:
Our study indicates that increased serum type I IFN activity in early SSc patients is associated with an antibody and laboratory profile that may reflect a subclinical overlap of SSc with other type I IFN-driven connective tissue diseases (CTDs).
AuthorsD M Wuttge, C Lood, E Tufvesson, A Scheja, L Truedsson, A A Bengtsson, R Hesselstrand
JournalScandinavian journal of rheumatology (Scand J Rheumatol) Vol. 42 Issue 3 Pg. 235-40 ( 2013) ISSN: 1502-7732 [Electronic] England
PMID23379597 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Interferon Type I
  • Ribonucleoproteins
Topics
  • Adult
  • Aged
  • Autoantibodies (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Interferon Type I (blood)
  • Male
  • Middle Aged
  • Ribonucleoproteins (immunology)
  • Scleroderma, Systemic (blood, immunology)
  • Sjogren's Syndrome (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: